ARTL (STOCKS)

    Artelo Biosciences, Inc. Common Stock

    $1.320000
    -0.040000 (-2.94%)
    Prev close: $1.360000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Gregory D. Gorgas
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $4.50M
    Employees
    6
    P/E (TTM)
    -0.03
    P/B (TTM)
    0.18
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Mar 2026)
    Assets $12.52M
    Current Assets $10.42M
    Noncurrent Assets $2.10M
    Intangible Assets $2.04M
    Other Non-current Assets $58.00K
    Liabilities $5.85M
    Current Liabilities $5.83M
    Noncurrent Liabilities $18.00K
    Equity $6.67M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $6.67M
    Liabilities And Equity $12.52M